Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2515 EUR | -1.37% | -10.34% | +9.35% |
Apr. 03 | TME Pharma: Fast Track designation in glioblastoma | CF |
Apr. 02 | TME Pharma N.V. Receives US FDA Fast Track Designation for Lead Asset NOX-A12 in Brain Cancer | CI |
- Stock Market
- Equities
- ALTME Stock
- News TME Pharma N.V.